Physician profile
Ruben Guzman
NPI 1316051881
$20,227.34
in general payments reported to CMS, 2019-2025
33 companies · $3,178 in 2025
The $3,178 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $28.58 · 2021: $6,996 · 2022: $1,427 · 2023: $491 · 2024: $7,757 · 2025: $3,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,315 · Food and Beverage: $3,036 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,315.46 |
| Food and Beverage | $3,035.76 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,857.17 | 2021-2025 | |
| Axonics, INC. | $3,901.55 | 2023-2024 | Axonics, Bulkamid |
| Medtronic, INC. | $1,646.73 | 2021-2022 | |
| Boston Scientific Corporation | $1,116.01 | 2024-2025 | Axonics, Solyx Sis System, Watchman Flx |
| Coloplast Corp | $1,023.88 | 2019-2025 | |
| Abbvie INC. | $253.89 | 2019-2023 | |
| Hologic Sales and Service, LLC | $194.85 | 2019-2024 | Thinprep 2000 Processor, Aptima |
| Astellas Pharma US INC | $177.48 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $132.45 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $125.28 | 2021-2023 | Slynd |
| Pfizer INC. | $91.70 | 2019-2023 | |
| Merz North America, INC. | $73.46 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $67.82 | 2019-2024 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $54.29 | 2024 | |
| Cvrx, INC. | $51.96 | 2024 | Barostim Neo System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $40.53 | 2019-2023 | Balcoltra |
| Allergan, INC. | $35.21 | 2021-2022 | |
| Dexcom, INC. | $31.94 | 2025 | Dexcom G6 Transmitter |
| Ge Healthcare | $31.35 | 2022 | |
| Ethicon US, LLC | $30.75 | 2021 | |
| Mayne Pharma Commercial LLC | $30.01 | 2021-2023 | |
| Impulse Dynamics (USA) INC. | $27.54 | 2024 | Optimizer |
| Laborie Medical Technologies Corp. | $27.06 | 2024 | Urgent PC Neuromodulation System, Eclipse |
| Medtronic USA, INC. | $25.00 | 2019 | |
| Lilly USA, LLC | $24.77 | 2024 | Jardiance |
| Coopersurgical, INC. | $23.72 | 2023 | Summit Doppler |
| Bluewind Medical | $22.08 | 2025 | |
| Scynexis, INC. | $21.56 | 2022 | |
| Organon LLC | $19.29 | 2022 | |
| Glaxosmithkline, LLC. | $17.46 | 2020 | |
| Myovant Sciences INC. | $17.21 | 2021 | |
| Evofem Biosciences, INC. | $17.15 | 2021 | |
| Dentsply Ih Ab | $16.19 | 2025 | Lofric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruben Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.